Application of exosomes derived from periodontal ligament stem cells in alleviating cell senescence and treating periodontitis
By extracting exosomes from periodontal lining stem cells and activating the KEAP1-NRF2 signaling pathway, the problem of PDLSCs aging in hyperglycemia is solved, and its biological function is restored, providing a potential for the treatment of diabetes periodontitis Anti-aging therapy.
Patent Information
- Application Number
- CN202310109433.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-02-14
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2043-02-14
AI Technical Summary
The treatment of diabetes periodontitis has achieved limited clinical success, and periodontal membrane stem cells (PDLSCs) are prone to aging in a hyperglycemia environment, resulting in a decrease in their regeneration potential and making it difficult to effectively repair periodontal tissue damage.
By extracting exosomes (PDLSC-Exos) from periodontal limb stem cells, miR-141-3p activates the KEAP1-NRF2 signaling pathway, alleviates the aging of PDLSCs in high-glycemic environments, restores their biological functions, and is used to treat teeth Periarthritis.
PDLSC-Exos significantly reduces the indicators related to cellular aging, restores the proliferation, migration and multidirectional differentiation capabilities of PDLSCs, delays the cellular aging process, and provides a potential anti-aging treatment method suitable for the treatment of diabetic periodontitis.
Smart Images

Figure BDA0004076194280000071 
Figure BDA0004076194280000081 
Figure BDA0004076194280000082
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biomedicine technology, and in particular to the application of exosomes derived from periodontal ligament stem cells in alleviating cell aging and treating periodontitis. Background Art
[0002] In recent decades, diabetes and its complications have become prevalent worldwide. Periodontitis is the sixth most common complication of diabetes and the main cause of tooth loss in adults, seriously affecting patients' health and quality of life. However, the treatment of diabetic periodontitis has achieved limited success in the clinic, but the development of tissue engineering and stem cell research has provided new opportunities for the repair of periodontal tissue damage. Human periodontal ligament stem cells (PDLSCs), also known as undifferentiated mesenchymal stem cells (MSCs), are widely considered to be ideal seed cells for periodontal tissue regeneration. According to previous reports, multiple factors affect the biological activity of PDLSCs, and hyperglycemia is one of the most common risk factors.
[0003] Cellular senescence is a state of permanent arrest of the cell cycle caused by internal or external factors. Hyperglycemia is a key extracellular stress signal that triggers cellular senescence. Hyperglycemia causes excessive oxidative stress, telomere shortening, epigenetic changes, and mitochondrial dysfunction, which triggers MSCs senescence. Multiple factors contribute to PDLSCs senescence, such as the induction of transforming growth factor-β, long-term in vitro culture, and overexpression of insulin-like growth factor binding protein 5. However, there are still few reports on the effects of high glucose levels on PDLSCs senescence. PDLSC senescence is accompanied by reduced proliferation potential, impaired multipotent differentiation ability, and increased apoptosis, which is not conducive to the repair and regeneration of periodontal defects. Therefore, delaying cellular senescence may be an emerging option to activate endogenous periodontal tissue repair mechanisms.
[0004] Exosomes are membrane-derived lipid bilayer vesicles secreted by various cells, which contain various cell-derived lipids, proteins, and nucleic acids. Exosomes can transport various signaling molecule components and regulate receptor cells through intercellular communication. The functions of stem cell-derived exosomes are similar to those of the stem cells from which they are derived, and may represent cell replacement for tissue regeneration and improve cell senescence through multiple pathways. For example, exosomes derived from deer antler stem cells alleviate osteoarthritis by counteracting the senescence of cells in the joint. In addition, exosomes produced by human embryonic stem cells stimulate the Kelch-like ECH-associated protein 1 (KEAP1)-nuclear factor erythroid 2-related factor 2 (NRF2) signaling pathway by transferring microRNA-200a (miR-200a), thereby alleviating the senescence of endothelial cells. Human periodontal ligament stem cell-derived exosomes (PDLSC-exos) are the main components of PDLSC paracrine factors and have a wide range of biological activities, including treatment of periodontitis-related bone abnormalities, stimulation of proliferation, angiogenesis, and immunomodulation. However, the functions and potential mechanisms of PDLSC-Exos in cell senescence are still uncertain.
[0005] According to the oxidative stress theory of aging, enhancing the body's antioxidant defense may be a therapeutic option to delay aging and extend lifespan. The KEAP1-NRF2 pathway is one of the most important cellular antioxidant systems, which controls the expression of many antioxidant enzymes. Previous studies have shown that NRF2 activity weakens during aging, and activation of NRF2 signaling can treat aging-related diseases or prevent cellular senescence and slow down the aging process. Activation of NRF2 can prevent cellular senescence in mesenchymal stem cells, fibroblasts, and dendritic cells, reduce the burden of cardiovascular disease in the elderly, and reverse the progression of age-related fibrotic diseases. Therefore, activation of NRF2 may be very important for improving aging and its related diseases. Mesenchymal stem cell-derived exosomes (MSC-Exos) have been reported to have excellent antioxidant properties, such as protecting oxidative stress-induced skin damage by regulating the NRF2 antioxidant defense system. Summary of the invention
[0006] The present invention studies the aging of PDLSCs under a high-sugar microenvironment, as well as the role and potential mechanism of PDLSC-Exos in alleviating cell aging. By isolating PDLSCs from the periodontal ligament, the effect of the high-sugar microenvironment on the aging of PDLSCs was evaluated, and the ability of PDLSC-Exos to reduce oxidative stress and improve cell aging was studied, verifying the molecular mechanism of PDLSC-Exos in improving PDLSC aging. Based on this, the present invention provides the following technical solutions:
[0007] Application of exosomes derived from periodontal ligament stem cells in the preparation of products that alleviate cell aging.
[0008] The method of alleviating cell aging is to alleviate the aging of periodontal ligament stem cells.
[0009] The alleviation of cell aging refers to alleviation of the aging of periodontal ligament stem cells in a high-sugar microenvironment.
[0010] The periodontal ligament stem cell-derived exosomes alleviate high glucose-induced PDLSCs senescence by transmitting miR-141-3p to activate the KEAP1-NRF2 signaling pathway.
[0011] The present invention also provides the use of exosomes derived from periodontal ligament stem cells in the preparation of a drug for treating periodontitis.
[0012] The periodontitis is diabetic periodontitis.
[0013] In the above technical solution, the periodontal ligament stem cells are human periodontal ligament stem cells.
[0014] In the above technical solution, the product or medicine consists of an active ingredient and pharmaceutically acceptable excipients, and the active ingredient is exosomes derived from periodontal ligament stem cells.
[0015] In the above technical solution, the exosome preparation method is to collect serum-free culture medium in which young periodontal ligament stem cells have been cultured, and extract exosomes by low-temperature ultracentrifugation.
[0016] In the above technical scheme, the exosome preparation method is: young periodontal ligament stem cells are cultured in a complete culture medium, and when the cell density reaches more than 60%, the culture medium is replaced with a serum-free culture medium, and the culture is continued for 44-52 hours, and then the cell supernatant is collected to obtain supernatant 1; the obtained supernatant 1 is subjected to differential centrifugation to obtain supernatant 2; the obtained supernatant 2 is subjected to ultracentrifugation and the supernatant is removed to obtain exosomes.
[0017] The present invention studies the aging of PDLSCs under a high-glucose microenvironment, as well as the role and potential mechanism of exosomes derived from human periodontal ligament stem cells (PDLSC-Exos) in alleviating cell aging. PDLSCs and PDLSC-Exos were separated and extracted, and then PDLSCs were treated with high-glucose (25mM) medium to evaluate cell aging indicators. PDLSC-Exos were co-cultured with aged PDLSCs to further explore the role of PDLSC-Exos in cell aging, and to detect the differences in cellular oxidative stress levels after PDLSC-Exo treatment. Next, we investigated whether PDLSC-Exos alleviated cell aging by restoring the balance of oxidative stress signals, and explored the potential molecular pathways. We found that high glucose induced premature aging of PDLSCs, while PDLSC-Exos treatment restored the vitality of senescent cells. When PDLSC-Exos were co-treated with the nuclear factor erythroid 2-related factor 2 (NRF2) inhibitor ML385 in aged PDLSCs, the cell viability-restoring effect of PDLSC-Exos was significantly inhibited, indicating that the therapeutic effect of PDLSC-Exos depends on the activation of NRF2. Further studies showed that microRNA-141-3p (miR-141-3p) was expressed at relatively high levels in PDLSC-Exos and promoted the PDLSC-Exos-mediated rejuvenation of aged cells by downregulating Kelch-like ECH-associated protein 1 (KEAP1), a negative regulator of NRF2 expression. Our results suggest that PDLSC-Exos alleviate high glucose-induced senescence of PDLSCs by activating the KEAP1-NRF2 signaling pathway through the delivery of miR-141-3p. Based on this study, PDLSC-Exos may behave similarly to their parent PDLSCs and have a significant effect on cellular senescence by delivering their encapsulated bioactive chemicals to target cells. This suggests that PDLSC-Exos, as a new candidate for cell-free therapy, may be a potential anti-aging agent and is expected to play a role in the treatment of diabetic periodontitis. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Figure 1 are the characteristics of human PDLSCs and PDLSC-Exos; AD isolation and passaging of human PDLSCs, the cells showed a typical spindle-shaped morphology; E calcified nodules Alizarin red staining proved that PDLSCs had osteogenic differentiation potential; F Oil red O staining showed that PDLSCs had adipogenic differentiation potential; G colony formation experiment showed the proliferation potential of PDLSCs; AG scale bar, 100μm; H TEM observation showed that PDLSC-Exos were typical cup-shaped, scale bar, 100nm; I WB showed that PDLSC-Exos expressed exosome marker proteins; JNTA showed the particle size and concentration of PDLSC-Exos.
[0019] Figure 2 The results showed that high glucose induced senescence of human PDLSCs; A SA-β-gal staining after 14 days of high glucose treatment, the proportion of SA-β-gal positive cells (blue) increased significantly, scale bar 100μm; B quantification of the percentage of SA-β-gal positive PDLSCs in each group; C Hoechst 33258 staining was used to observe cell apoptosis, and the apoptotic cell nucleus was condensed (white arrow), scale bar 100μm; D IF staining was used to determine the expression of p16 (green), scale bar 100μm; E-FWB detected the quantitative analysis of the expression of cell senescence-related proteins (p53 and p21); G qRT-PCR method was used to quantify the expression of SASP genes (IL-6 and IL-8).
[0020] Figure 3 It shows that the function of senescent PDLSCs induced by high glucose is impaired; AB used CCK-8 test and colony formation experiment to evaluate the proliferation ability of PDLSCs, scale bar 100μm; wound healing experiment CD and Transwell experiment EF were used to detect cell migration, scale bar 100μm; GH PDLSCs were induced 7 days later and the osteogenic ability of cells was evaluated by ALP staining and activity assay, scale bar 100μm; IJ used Alizarin red staining and quantification to evaluate cell calcium deposition, scale bar 100μm; KL Oil red O staining and quantification showed that all three groups of cells had the ability to differentiate into adipocytes, scale bar 100μm.
[0021] Figure 4 It showed that PDLSCs-Exos improved the high glucose-induced senescence of human PDLSCs; A aged PDLSCs took up Dill-labeled exosomes, scale bar 100μm; B SA-β-gal stained cell image, scale bar 100μm; C quantification of the percentage of SA-β-gal positive PDLSCs in each group; D IF detected p16 expression (green), scale bar 100μm; E-FWB detected and quantified the expression of senescence-related proteins p53 and p21; G qRT-PCR was used to detect the expression of SASP genes (IL-6 and IL-8).
[0022] Figure 5It showed that PDLSCs-Exos could restore the dysfunction of senescent PDLSCs induced by high glucose; AB used CCK-8 method and colony formation assay to detect the proliferation ability of PDLSCs, scale bar 100μm; wound healing CD and Transwell assay EF were used to evaluate cell migration, scale bar 100μm; G-HALP staining / activity assay, scale bar 100μm; IJ Alizarin red staining and mineralized nodule quantification, scale bar 100μm; KL Oil red O staining was used to quantitatively determine the adipogenic differentiation ability of the three groups of cells, scale bar 100μm.
[0023] Figure 6 The results showed that PDLSC-Exos reduced oxidative stress and increased the activity of endogenous NRF2 antioxidant system; AB evaluated the intracellular ROS level by measuring DCFH-DA fluorescence, scale bar 100 μm; CD detected the cellular oxidative stress level by detecting MDA level and SOD activity; EF showed the expression levels of total NRF2, nuclear NRF2, KEAP1, HO-1, and NQO1 proteins in each group; G IF staining showed the localization of NRF2 (green), scale bar 100 μm.
[0024] Figure 7 The results showed that PDLSC-Exos rejuvenated aged human PDLSCs by activating NRF2; AB WB analyzed the levels of total NRF2, nuclear NRF2, HO-1 and NQO1 in each group; C IF staining detected the expression and localization of NRF2 (green), scale bar 100μm; DE cells were stained with SA-β-gal, and the percentage of SA-β-gal positive cells was calculated, scale bar 100μm; FG WB detected and quantified the expression of senescence-related proteins (p53 and p21); H IF staining showed p16 expression, scale bar 100μm; I qRT-PCR was used to detect the expression levels of SASP genes (IL-6, IL-8); J DCFH-DA staining was used to detect and quantify the cellular ROS level, scale bar 100μm; LM determined the MDA level and SOD activity.
[0025] Figure 8It shows that PDLSC-Exos enhance the biological function of aging PDLSCs in an NRF2-dependent manner. A Cell proliferation was detected by CCK-8. B Cell colony formation was evaluated by colony formation assay. Scale bar, 100μm. Cell migration was evaluated by wound healing assay CD and Transwell assay EF. Scale bar, 100μm. After GH osteogenic induction for 7 days, PDLSC osteogenesis was evaluated by ALP staining and activity assay. Scale bar, 100μm. IJ Alizarin red staining and quantification after 21 days of osteogenic induction to evaluate cell calcium deposition. Scale bar, 100μm. KL Oil red O staining was used to detect cell adipogenic differentiation. Scale bar, 100μm.
[0026] Fig. 9 It showed that miR-141-3p delivered by PDLSC-Exos activated NRF2 signaling by reducing the expression of KEAP1; A Venn diagram of predicted miRNAs (hsa-miR-141-3p, hsa-miR-200a-3p) targeting the KEAP1 gene; B qRT-PCR detection of changes in miRNA expression levels in human PDLSCs before and after high glucose treatment; C qRT-PCR detection of the expression of selected miRNAs in PDLSC-Exos. D: qRT-PCR was used to detect the expression of miR-141-3p; EF: dual luciferase reporter gene experiment was used to verify the targeting relationship between miR-141-3p and KEAP1; G: qRT-PCR analysis was used to determine the expression level of miR-141-3p in aged PDLSCs treated with PDLSC-Exos; HI: WB was used to determine the expression levels of total NRF2, nuclear NRF2, KEAP1, HO-1 and NQO1 proteins, and quantitative analysis was performed using ImageJ software; J: NRF2 was located by IF staining, scale bar 100 μm.
[0027] Fig.10 The results showed that exosomal miR-141-3p from PDLSCs was essential for delaying high glucose-induced PDLSC senescence; AB SA-β-gal staining images and percentage of SA-β-gal positive cells, scale bar 100μm; CD WB analysis of p53 and p21 expression levels; E IF staining detection of p16 expression, scale bar 100μm; F relative levels of SASP genes IL-6 and IL-8; G DCFH-DA staining detection and quantification of cellular ROS levels, scale bar 100μm; IJ MDA level and SOD activity were detected to evaluate cellular oxidative stress levels.
[0028] Fig.11It showed that PDLSC-Exos restored cell biological functions by regulating the miR-141-3p / KEAP1 / NRF2 axis in aged PDLSCs; AB evaluated cell proliferation by CCK-8 and colony formation assays, scale bar 100 μm; cell migration was detected by wound healing CD and Transwell EF assays, scale bar 100 μm; GH alkaline phosphatase staining and activity assay, scale bar 100 μm; IJ observed and determined calcium deposition by Alizarin Red staining, scale bar 100 μm; K Oil Red O staining, scale bar 100 μm; L Oil Red O staining quantification. DETAILED DESCRIPTION
[0029] The present invention will be further described below in conjunction with embodiments, but the present invention is not limited thereto.
[0030] The experimental methods in the following examples are conventional methods unless otherwise specified.
[0031] Example 1
[0032] 1. Materials and Methods
[0033] 1.1 Cell culture and identification
[0034] After obtaining informed consent from all patients, PDLSCs were extracted from healthy wisdom teeth or orthodontic teeth of young patients. The freshly extracted teeth were washed with phosphate-buffered saline (PBS), and the middle 1 / 3 of the root surface was scraped to collect the periodontal ligament tissue. Next, it was digested with type I collagenase solution (3 mg / mL) (Sigma-Aldrich, St. Louis, MO, USA) at 37°C for 15 minutes, and then 5 mL of α-MEM medium was added, supplemented with penicillin-streptomycin solution (1%) and fetal bovine serum (FBS; Gibco, Grand Island, NY, USA) (10%). Subsequently, the tissue in the flask was incubated at 37°C, 5% CO 2 After the cells were observed to migrate out of the tissue, the culture medium was changed, and the cells were subcultured. The third generation of cells were used for subsequent cell identification. The multidirectional differentiation potential and colony formation ability of PDLSCs were verified by Alizarin red staining, Oil Red O staining and colony formation experiments.
[0035] 1.1.1 Alizarin red staining
[0036] Cells were seeded in 6-well plates (5×10 5 cells / well). When the cell growth density reached 80%, osteogenic induction medium was added and the medium was replaced every 2 days. After 21 days of osteogenic induction, Alizarin red staining (Biyuntian Biotechnology Research Institute, Shanghai, China) was performed. Cetylpyridinium chloride was used to dissolve the calcified nodules and the absorbance was measured at 562 nm.
[0037] 1.1.2 Oil Red O staining
[0038] Cells were seeded in 6-well plates (5×10 5 cells / well). When the cell density reached 80%, the medium was replaced with adipogenic medium. After 14 days of continuous culture, the cells were stained with Oil Red O. The stained lipid droplets were dissolved in isopropanol and the absorbance was measured at 520 nm. The kit used in this experiment was produced by Solebao Co., Ltd. (Beijing, China).
[0039] 1.1.3 Colony formation assay
[0040] The cells were cultured in 60 mm dishes (800 cells / dish). After 14 days of continuous culture, the cells were fixed with 4% paraformaldehyde (PFA) and then stained with 0.1% crystal violet. After staining, the excess dye was washed away and the cell colony formation was observed under a microscope. Cell aggregates with more than 50 cells were considered as a colony.
[0041] 1.2 Effect of high glucose on PDLSC senescence
[0042] The second generation of PDLSCs from the same donor were continuously cultured in high glucose medium (HG group, 25mM glucose) to explore the effect of high glucose environment on PDLSC aging. The medium was replaced every 2 days, and the cells were passaged when 80% confluence was reached. The control group was cultured in high concentration mannitol (HM group, osmotic pressure control, 5.5mM glucose + 19.5mM mannitol) or normal glucose medium (NG group, 5.5mM glucose). The senescence-associated β-galactosidase (SA-β-gal) activity of cells in each group was monitored at different time intervals (7, 14, 21 and 28 days) to determine the time of high glucose-induced cell senescence. The apoptotic morphology of the HG group was observed by Hoechst 33258 staining at different time points (7, 14, 21, 28 days) to distinguish apoptosis from cell senescence. In subsequent studies, we used cells that were cultured continuously for 14 days in each group. Western blotting (WB) or immunofluorescence (IF) staining was used to detect the expression of senescence-related proteins (p53, p21 and p16) to assess cell senescence. Real-time quantitative PCR (qRT-PCR) was used to analyze the expression of interleukin 6 (IL-6) and interleukin 8 (IL-8) in the senescence-associated secretory phenotype (SASP).
[0043] Next, we examined cell proliferation, migration, and multidirectional differentiation to evaluate changes in cell biological functions after high glucose-induced senescence. Cell proliferation was assessed using a cell counting kit-8 (CCK-8) and colony formation assay (see “Colony formation assay” section); wound healing and Transwell assays were performed to detect cell migration; alkaline phosphatase (ALP), Alizarin red staining (see “Alizarin red staining” section), and Oil Red O staining (see “Oil Red O staining” section) were used to detect cell multidirectional differentiation ability.
[0044] 1.2.1 SA-β-gal staining
[0045] The SA-β-gal activity of each group of cells was identified using a SA-β-gal staining kit. SA-β-gal-positive cells were observed to be blue under a microscope. Three fields of view were randomly selected from each sample (each field of view had at least 100 cells), and the percentage of SA-β-gal-positive cells was calculated as: (SA-β-gal-positive cells / total cells in the field of view) × 100%. The kit used in this study was manufactured by Bio-Technology Research Institute Co., Ltd. (Shanghai, China).
[0046] 1.2.2 Hoechst 33258 staining
[0047] The apoptosis of PDLSCs in the high glucose-induced group was detected using the Hoechst 33258 apoptosis staining kit. The cells were fixed at appropriate time intervals and stained with Hoechst 33258 staining solution. The state of the cell nucleus was observed under a fluorescence microscope. The kit used in this experiment was produced by Biotech Research Institute (Shanghai) Co., Ltd.
[0048] 1.2.3 Immunofluorescence staining
[0049] Each group of cells was cultured in a 24-well plate and fixed with 4% PFA when the cell density reached about 70%. The cells were then permeabilized with 0.1% Triton X-100 for 10 min and blocked with goat serum (Biyuntian Biotechnology Institute, Shanghai, China) for 30 min. The cells were incubated with the primary antibody at 4 °C overnight and then with the secondary antibody at room temperature for 1 h. They were then stained with 4',6-diamidino-2-phenylindole (DAPI). The cells were observed using a fluorescence microscope. The antibodies used in this experiment are listed in Table 1.
[0050] Table 1: List of antibodies used in this study
[0051]
[0052]
[0053] 1.2.4 Protein immunoblotting
[0054] Total protein and nuclear protein were extracted using RIPA strong lysis buffer (containing protease and phosphatase inhibitors) and nuclear and cytoplasmic protein extraction kit (Biosharp Biotechnology Research Institute, Shanghai, China), respectively. Protein concentration was determined using a BCA kit. Protein samples were separated by polyacrylamide gel electrophoresis using sodium dodecyl sulfate. Proteins were transferred to PVDF membranes and then blocked with 5% skim milk for two hours at room temperature. Protein bands were incubated with primary antibodies at 4°C overnight and then with secondary antibodies for 1 hour at room temperature. Finally, proteins were detected using enhanced chemiluminescence reagents (Biosharp, Hefei, China). Spectral density analysis was performed using ImageJ software. The internal reference for total cell protein quantification in this experiment was GAPDH, and the internal reference for nuclear protein quantification was histone H3. The secondary antibody was goat anti-rabbit IgG secondary antibody (1:5000, Affinity Biosciences, Jiangsu, China). The antibodies used in this experiment are shown in Table 1.
[0055] 1.2.5 qRT-PCR analysis of mRNA levels
[0056] Total RNA was extracted from cells using TRIzol and cDNA was synthesized using a reverse transcription kit. TM II was used for real-time quantitative polymerase chain reaction. The expression of the main SASP factors IL-6 and IL-8 was detected. The internal control was GAPDH. Takara (Tokyo, Japan) produced the kit used in this study, and the primer sequences used to detect each gene sequence are listed in Table 2.
[0057] Table 2: mRNA primers used for qRT-PCR.
[0058]
[0059] The PCR amplification program for qRT-PCR was: pre-denaturation at 95°C for 30 seconds; 95°C for 5 seconds, 60°C for 30 seconds, and 40 cycles.
[0060] 1.2.6CCK-8 detection
[0061] CCK-8 detection was performed using a CCK-8 kit (ApexBio Technology, MA, USA). Cells were seeded in 96-well plates (1×10 3 Cells / well), add 10 μL CCK-8 detection solution and 100 μL culture medium to each well, incubate at 37°C for 2 hours. Use a microplate reader to measure the absorbance value (OD value) at 450 nm.
[0062] 1.2.7 Wound healing assay
[0063] Cells were seeded in 6-well plates. A 200 μL pipette was used to scratch the cell monolayer. Optical microscopy was used to take photos and record at predetermined time intervals (0 hours, 24 hours, and 48 hours). Calculations were performed based on the initial scratch area to determine the change in scratch area over time and the proportion of wound healing. Wound healing rate (%) = (0 hour scratch area - specific time point scratch area) / 0 hour scratch area × 100.
[0064] 1.2.8 Transwell migration assay
[0065] Each group of cells (4×10 4 cells / well) were inoculated in the upper wells of a Transwell 24-well plate, and medium containing 10% exosome-free FBS (750 μL / well) was added to the lower wells. After incubation for 24 hours, the cells were preserved with 4% PFA and stained with 0.1% crystal violet. Then, the cells on the inner surface of the membrane were removed and images of the stained cells were taken using an inverted microscope. The crystal violet-stained cells were washed with 33% acetic acid, and the absorbance of the solution was measured at OD 570nm.
[0066] 1.2.9 ALP staining and activity assay
[0067] The cells were plated at 5×10 5 The cells were seeded in 6-well plates at a density of 100 μg / mL. After the cell density reached 80%, the culture medium was replaced with osteogenic induction medium. ALP staining was performed after one week of osteogenic induction culture. The alkaline phosphatase level was quantitatively determined using the alkaline phosphatase detection kit from Biotech Research Institute (Shanghai, China).
[0068] 1.3 Extraction and identification of exosomes
[0069] Exosomes were extracted by low-temperature ultracentrifugation. Young PDLSCs were cultured in complete medium. When the cell density reached 70%, the medium was replaced with serum-free medium, cultured for 48 h, and then the cell supernatant was collected. The conditioned medium obtained (i.e., the supernatant obtained previously) was centrifuged at 300 × g for 15 minutes, the supernatant was taken, and then centrifuged again at 3,000 × g for 15 minutes. The resulting supernatant was centrifuged twice at 100,000 × g for 70 minutes each. After removing the supernatant, the exosome-containing pellet was resuspended in cold PBS and stored at -80°C until use in subsequent experiments. In experiments involving exosomes, the same volume of PBS was used as a control.
[0070] The exosome concentration was determined using a BCA assay kit. The morphology of PDLSC-Exos was characterized using transmission electron microscopy (TEM). The particle size and concentration of exosomes were assessed using nanoparticle tracking analysis (NTA). WB was used to identify exosome surface markers such as CD9, CD63, CD81, TSG101, and calnexin (see the “Western immunoblotting” section).
[0071] 1.4 Effects of PDLSC-Exos Treatment on Aging PDLSCs
[0072] We first determined whether PDLSC-Exos could be taken up by senescent PDLSCs. Senescent PDLSCs were treated with 25, 50, and 100 μg / mL PDLSC-Exos for 72 h to determine the appropriate PDLSC-Exo treatment concentration. The response of high glucose-induced cell senescence to PDLSC-Exo treatment was assessed by SA-β-gal staining (see the “SA-β-gal staining” section). Subsequently, we selected 50 μg / mL PDLSC-Exos to co-incubate with senescent PDLSCs for 72 h (HG-Exos group), and the PDLSCs in the control group received the same volume of PBS (HG group) or normal glucose (NG group, not treated with high glucose). Similarly, the expression of senescence-related proteins was detected by WB (see the “Western immunoblotting” section) or IF staining (see the “Immunofluorescence staining” section). In addition, the expression of two SASP genes was assessed by qRT-PCR (see the “qRT-PCR analysis of mRNA levels” section). We examined cell proliferation, migration, and multidirectional differentiation to determine changes in cell biological functions (see section “1.2 Effects of high glucose on PDLSC aging”).
[0073] 1.4.1 Exosome endocytosis experiment
[0074] Exosomes were labeled with the fluorescent dye Dil (red) to assess the uptake of PDLSC-Exos by senescent PDLSCs. Briefly, 2 μL Dil was added to the isolated exosomes (1 mL, 100 μg / mL protein concentration) to a final concentration of 10 μM. Dil-labeled exosomes were incubated at 37°C for 30 min and then re-centrifuged. Senescent PDLSCs were incubated with labeled exosomes at 37°C for 24 h. Next, the cells were fixed, the nuclei were stained with DAPI, and the uptake of exosomes by senescent PDLSCs was observed using an inverted fluorescence microscope. The reagents used in this study were developed by Biotech Research Institute (Shanghai) Co., Ltd.
[0075] 1.5 Role of NRF2 in PDLSC-Exos-mediated regeneration of aged PDLSCs
[0076] Before and after PDLSC-Exo treatment of aged PDLSCs, we measured ROS levels, malondialdehyde (MDA) content, and superoxide dismutase (SOD) activity to assess cellular oxidative stress. We used WB technology to identify the expression levels of NRF2 and NRF2 downstream target proteins NADPH quinone oxidoreductase 1 (NQO1) and heme oxygenase 1 (HO-1) in cells to detect whether NRF2 is involved in the regeneration of aged PDLSCs mediated by PDLSC-Exos (see the "Western immunoblotting" section). In addition, IF staining (see the "Immunofluorescence staining" section) was used to detect the expression and intracellular distribution of NRF2.
[0077] High-glucose-induced senescent PDLSCs were cultured in the following groups to explore the effect of NRF2 activation on PDLSC-Exo-mediated recovery of senescent PDLSCs: (1) HG group (PBS treatment), (2) HG-Exos group (50 μg / mL PDLSC-Exo treatment), and (3) HG-Exos-ML385 (MedChem Express, Monmouth Junction, NJ, USA) group (50 μg / mL PDLSC-Exos and 5 μM ML385). Similarly, the level and localization of NRF2 in each group were detected as described above. Cell senescence, oxidative stress, and biological functions were then detected to evaluate the role of ML385 treatment in PDLSC-Exos-mediated recovery of senescent cell viability.
[0078] 1.5.1 Determination of oxidative stress level
[0079] Intracellular ROS levels were measured using a ROS detection kit according to the manufacturer's instructions. Briefly, 10 μmol / L of DCFH-DA probe was added to the cells and incubated at 37 °C for 20 min. Fluorescence intensity was analyzed using a fluorescence microscope and a microplate reader and the formation of ROS was evaluated. To determine the MDA level and SOD activity, the cells were lysed and the cell supernatant was collected. MDA levels and SOD activity were determined using a commercial kit according to the manufacturer's instructions. The kit used in this experiment was produced by Biotech Research Institute (Shanghai) Co., Ltd.
[0080] 1.6 Role of the microRNA-141-3p (miR-141-3p) / KEAP1 / NRF2 axis in PDLSC-Exos-mediated senescent cell regeneration
[0081] The expression level of KEAP1 (a negative regulator of NRF2) in senescent PDLSCs and its expression changes after PDLSC-Exos treatment were detected by WB (see the “Western immunoblotting” section). Then, we detected miRNAs that specifically target KEAP1 to regulate NRF2 activity. Using qRT-PCR technology, the expression levels of two miRNAs (miR-141-3p and miR-200a-3p) screened in the early stage were detected in normal and senescent PDLSCs and PDLSC-Exos. Then, the expression of miR-141-3p in cells was detected after PDLSC-Exo treatment of senescent PDLSCs. The targeting relationship between KEAP1 and miR-141-3p was verified by dual luciferase reporter gene experiments. We downregulated the expression level of miR-141-3p in PDLSC-Exos using a miR-141-3p inhibitor to verify the molecular mechanism of PDLSC-Exos regulating the NRF2 signaling pathway. Then, high-glucose-induced senescent PDLSCs were divided into three groups: (1) HG group (PBS treatment), (2) HG-NCI-Exos group (50 μg / mL NCI-Exo treatment, PDLSCs exosomes transfected with Inhibitor negative control), (3) HG-141I-Exos group (50 μg / mL 141I-Exo treatment, PDLSCs exosomes transfected with miR-141-3p Inhibitor). Subsequent experiments were performed according to the above classification. The expression of proteins in the NRF2 pathway was identified by WB (see the “Western immunoblotting” section) and IF staining (see the “Immunofluorescence staining” section). In addition, we also evaluated the senescence, oxidative stress levels, and biological functions of cells in each group.
[0082] 1.6.1 MiRNA Screening
[0083] Using Venn diagram, candidate miRNAs targeting KEAP1 were screened based on cross-filtering of miRNA databases (miRWalk, StarBase, miRDB, miRcode, and TargetScan). In addition, the keywords "microRNA, cell senescence, periodontal ligament stem cells, periodontal disease, oxidative stress, mesenchymal stem cells, KEAP1-NRF2" were searched in PubMed to determine whether these previously screened miRNAs were expressed in periodontal tissues and involved in cell senescence, oxidative stress, and periodontal disease.
[0084] 1.6.2 qRT-PCR detection of miRNA levels
[0085] Total exosome RNA was extracted using the BIOG Exosome RNAEasy Kit, and miRNA was reverse transcribed using the BIOG miRNAPolyA+RTKit. qRT-PCR was performed using the BIOG miRNA PolyA SYBR qPCR Kit. The expression of target genes miR-141-3p and miR-200a-3p was detected by qRT-PCR. The internal control for miRNA analysis was U6. The kit used in this experiment was produced by Changzhou Baida Biotechnology Co., Ltd. (China), and the primer sequences are shown in Table 3.
[0086] Table 3: miRNA primers used for qRT-PCR.
[0087]
[0088]
[0089] PCR amplification program for qRT-PCR: activation of Taq: 95°C for 2 min;
[0090] PCR cycle: 95°C for 10 s, 60°C for 30 s; 40 cycles;
[0091] Melting curve: 95℃15s; 60℃1min; 95℃15s; 1 cycle.
[0092] 1.6.3 Dual luciferase reporter gene assay
[0093] The 3'UTR of KEAP1 mRNA was searched in the China National Center for Biotechnology Information database, and the sequence was generated and cloned downstream of the luciferase minigene in the pmirGLO vector (luciferase reporter vector). The 3'UTR of the putative miR-141-3p target sequence was altered using a site-directed mutagenesis kit (Umibio, Shanghai, China). Each product was sequenced. The miR-141-3p sequence was also determined and synthesized. One day before transfection, HEK293 cells were seeded in 48-well plates (1 × 10 5Cells / well). Transfection was performed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Cells were transfected with pmirGLO luciferase expression constructs containing the 3'UTR of the KEAP1 gene, pRL-TK Renilla luciferase vector (Promega, Madison, WI, USA) and miRNA negative control (Ambion, Austin, TX, USA). Luciferase activity was assessed 48 hours after transfection using a dual luciferase reporter gene kit from Promega (Madison, WI, USA) and normalized to Renilla luciferase activity.
[0094] 1.6.4 Transfection of miRNA inhibitors
[0095] PDLSCs were transfected with 100 nM miR-141-3p Inhibitor (Ribo Bio, Guangzhou, China) and Inhibitor negative control according to the manufacturer's instructions. The transfection kit was Lipofectamine RNAiMAX (ThermoFisher Scientific, Waltham, MA, USA) kit. The transfected cells were cultured in serum-free medium for 48 hours. Exosomes were isolated from the cell culture supernatant using a previously described method.
[0096] 1.7 Statistical analysis
[0097] Each experiment was performed at least three times using PDLSCs from the same donor. Statistical analysis was performed using GraphPad Prism 9 software. All results are expressed as mean ± standard deviation (SD). Student t test was used to test whether the differences between groups were statistically significant. Analysis of variance (ANOVA) was used for multiple comparisons. Each experiment was repeated using PDLSCs from at least three independent donors. The results were considered statistically significant when p<0.05 (*), p<0.01 (**), p<0.001 (***), or p<0.0001 (****).
[0098] 2 Results
[0099] 2.1 Characterization of PDLSCs and PDLSC-Exos
[0100] PDLSCs are derived from young and healthy teeth ( Figure 1 A). Primary cells grow from the center of the tissue to the periphery ( Figure 1 B). After passage, the cells grew actively, showed typical fibroblast-like morphology, and were arranged in a whorl shape ( Figure 1C and D). Alizarin red and Oil Red O staining confirmed that PDLSCs have osteogenic differentiation ( Figure 1 E) and adipogenic differentiation ( Figure 1 F) Potential. The stemness of cells was identified by colony formation assay ( Figure 1 G).
[0101] PDLSC-Exos were extracted from the supernatant of young PDLSCs and further characterized by TEM, WB, and NTA. TEM analysis showed that PDLSC-Exos had a typical cup-shaped morphology ( Figure 1 H). WB showed that PDLSC-Exos expressed exosome-specific markers CD9, CD81, CD63, and TSG101, but did not express calnexin ( Figure 1 I). According to NTA data, the concentration of PDLSC-Exos is 3.9×10 10 particles / mL, with an average particle size of 113.8 nm ( Figure 1 J). These results indicate that the PDLSC-Exos we extracted have the basic characteristics of exosomes.
[0102] 2.2 High glucose induces premature senescence of PDLSCs
[0103] After 14 days of high glucose treatment, the number of SA-β-gal positive cells increased significantly compared with the NG and HM groups ( Figure 2 A and B), but no obvious apoptosis was observed ( Figure 2 C). Therefore, we selected 14 days of induction as the time point for high glucose treatment of PDLSCs in subsequent experiments. After high glucose induction, the levels of senescence-related proteins (p53, p21 and p16) Figure 2 DF) and the levels of two main indicators of SASP (IL-6 and IL-8) ( Figure 2 G) also increased significantly. Based on these results, continuous culture in high-glucose medium can induce premature senescence of PDLSCs. The results of cell biological function experiments showed that high-glucose-induced senescent PDLSCs had decreased proliferation, migration, osteogenic and adipogenic differentiation ( Figure 3 ). Based on these results, continuous culture in high-glucose medium can induce premature senescence of PDLSCs.
[0104] 2.3PDLSC-Exos alleviate high glucose-induced PDLSCs senescence
[0105] To further determine the role of PDLSC-Exos in delaying cell senescence, we first used Dill-labeled exosomes to test the ability of PDLSC-Exos to internalize. Red fluorescence was observed around the nuclei of senescent PDLSCs co-cultured with exosomes, indicating the presence of Dill-labeled PDLSC-Exos ( Figure 4 A); The results showed that PDLSC-Exos entered the aged PDLSCs through endocytosis and dispersed in the cytoplasm. According to the results of SA-β-gal staining, PDLSC-Exo treatment significantly reduced the SA-β-gal activity of aged PDLSCs in a concentration-dependent manner ( Figure 4 B and C), especially when the concentration of PDLSC-Exos reached 50 μg / mL, the SA-β-gal positive staining rate in the HG-Exos group was significantly reduced, similar to that in the NG group. Therefore, we used 50 μg / mL of PDLSC-Exos in subsequent experiments, and the other groups used an equal amount of PBS as a placebo. In addition, PDLSC-Exos downregulated the expression levels of p53, p21, and p16 in senescent PDLSCs ( Figure 4 DF), and the expression levels of IL-6 and IL-8 ( Figure 4 G).
[0106] Since the biological functions of PDLSCs decline during aging, we next investigated the effects of PDLSC-Exos treatment on the biological characteristics of high glucose-induced senescent PDLSCs. Figure 5 A) and colony formation assay ( Figure 5 B) The results showed that incubation with PDLSC-Exos could restore the proliferation of high glucose-induced senescent PDLSCs. Figure 5 C and D) and Transwell assay ( Figure 5 E and F) both showed that PDLSC-Exo treatment can improve the decreased migration potential of aged PDLSCs. In addition, incubation of aged PDLSCs with PDLSC-Exos can improve the osteogenesis of cells ( Figure 5 GJ) and adipogenic differentiation ( Figure 5 K and L). Overall, these findings suggest that PDLSC-Exo treatment reduces the senescent phenotype of PDLSCs and restores the viability of aged PDLSCs to a level roughly comparable to that of young cells.
[0107] 2.4PDLSC-Exos rejuvenate aged PDLSCs by activating NRF2
[0108] The most common type of stress that causes cell senescence in vitro is oxidative stress. We first detected the level of ROS in PDLSCs to determine the mechanism by which PDLSC-Exos exert anti-aging effects. Figure 6 As shown in A and B, the intracellular ROS level increased significantly in high glucose-induced senescent PDLSCs, but this effect was almost completely abolished after incubation with PDLSC-Exos. We also measured the MDA level and SOD activity and found that the MDA level in the HG group was significantly higher than that in the NG group ( Figure 6 C), while the antioxidant activity of SOD was significantly lower than that of NG group ( Figure 6 D). These changes in aged PDLSCs were largely reversed after treatment with PDLSC-Exos. Therefore, PDLSC-Exos can reduce oxidative stress in aged PDLSCs. NRF2 plays a key role in regulating redox and metabolic homeostasis, oxidative stress, and other cytoprotective responses. Subsequently, we investigated the anti-aging mechanism of PDLSC-Exos on aged PDLSCs by evaluating whether PDLSC-Exos might promote NRF2 nuclear translocation and activate its downstream signaling pathways. According to our results, aged PDLSCs exhibited lower levels of expression of NRF2 signaling-related proteins (NRF2, NQO1, and HO-1). PDLSC-Exo treatment can restore the expression levels of NRF2 signaling-related proteins in senescent cells ( Figure 6 E and F), promoting NRF2 nuclear translocation ( Figure 6 G).
[0109] Aged PDLSCs were incubated with NRF2-specific inhibitor ML385 and PDLSC-Exos to further determine whether PDLSC-Exos delay aging by upregulating NRF2. The results confirmed that ML385 could prevent PDLSC-Exos-mediated NRF2 upregulation ( Figure 7 A and B) and nuclear translocation ( Figure 7 C). PDLSC-Exos did not reduce SA-β-gal activity in ML385-treated aged PDLSCs ( Figure 7 D and E) or senescence-associated proteins ( Figure 7 The expression levels of FH and SASP genes ( Figure 7 I). In addition, ML385 significantly inhibited the reduction of oxidative stress mediated by PDLSC-Exos ( Figure 7 JM). The improvement of the functional phenotype of aged PDLSCs is related to the NRF2 signaling pathway. The improvement of the functional phenotype of aged PDLSCs is related to the NRF2 signaling pathway. After the addition of ML385, the ability of PDLSC-Exos to improve the biological functions of aged PDLSCs such as cell proliferation, migration and differentiation was significantly inhibited ( Figure 8 Based on these results, PDLSC-Exos inhibited PDLSC senescence and delayed senescent phenotypes by promoting NRF2 accumulation and nuclear translocation and reducing ROS levels.
[0110] 2.5PDLSC-Exos activate NRF2 and downregulate KEAP1 expression by delivering miR-141-3p
[0111] In subsequent experiments, we sought to gain more information about the potential mechanisms of NRF2 activation. KEAP1 negatively regulates NRF2 activity; therefore, we examined KEAP1 protein expression. KEAP1 expression increased in aged PDLSCs after PDLSC-Exo treatment, but its expression level decreased after PDLSC-Exos treatment ( Figure 6 E and F), suggesting that PDLSC-Exos may activate NRF2 signaling by inhibiting KEAP1 expression. According to previous reports, exosomal miRNAs may be delivered to recipient cells by post-transcriptionally controlling the expression of host genes, thereby altering their function. By reviewing relevant literature and performing comprehensive bioinformatics analysis, we found that miR-141-3p and miR-200a-3p were associated with periodontal disease and regulated NRF2 activity by targeting KEAP1 expression ( Fig. 9 A). We detected the expression levels of these two miRNAs in PDLSCs and PDLSC-Exos to further verify the molecular mechanism of PDLSC-Exos in regulating the NRF2 signaling pathway. Notably, miR-141-3p was significantly downregulated in high-glucose-induced senescent PDLSCs, while its expression was significantly enriched in PDLSC-Exos ( Fig. 9 B and C). After incubation with PDLSC-Exos, the expression of miR-141-3p was significantly increased in senescent PDLSCs ( Fig. 9 D), consistent with the downregulation of KEAP1 expression. The results of the dual luciferase reporter gene assay showed that cells co-transfected with miR-KEAP1-WT and miR-141-3p mimics showed a significant decrease in luciferase reporter gene activity. In cells co-transfected with miR-141-3p mimics and pmiR-KEAP1-MUT, no decrease in luciferase activity was observed ( Fig. 9 E and F). These results revealed a clear targeting relationship between miR-141-3p and KEAP1.
[0112] We then downregulated miR-141-3p levels in PDLSC-Exos ( Fig. 9G) and co-cultured them with senescent PDLSCs to study the function of miR-141-3p in PDLSC-Exos and improve high glucose-induced PDLSCs senescence. Knockdown of miR-141-3p almost completely reversed the effects of PDLSC-Exos on downregulating KEAP1 expression and upregulating NRF2 expression ( Fig. 9 HJ). In addition, downregulation of miR-141-3p blocked the effects of PDLSC-Exos on the senescent phenotypes of senescent PDLSCs (SA-β-gal activity, senescence-associated protein expression, and SASP levels) ( Fig.10 ) and biological functions (proliferation, migration and multidirectional differentiation) ( Fig.11 ). These findings suggest that miR-141-3p is one of the main mediators of PDLSC-Exos regenerating senescent PDLSCs by inhibiting KEAP1 expression and activating NRF2. That is, PDLSC-Exos prevent high glucose-induced PDLSC senescence by transferring miR-141-3p to senescent PDLSCs, reducing KEAP1 expression and activating the NRF2 antioxidant pathway.
[0113] In summary, high levels of glucose induced premature senescence of PDLSCs, while PDLSC-Exos promoted the regeneration of aged PDLSCs. PDLSC-Exos may play an anti-aging role by transmitting miR-141-3p to downregulate KEAP1 expression and activate the NRF2 antioxidant pathway. This study can provide a certain theoretical basis for the application of cell-free therapy in the prevention and treatment of diabetic periodontitis. The present study confirmed that PDLSC-Exos is expected to be a new type of bioactive drug for anti-cellular senescence and has good application prospects.
Claims
1. Application of exosomes derived from periodontal ligament stem cells in the preparation of drugs for the treatment of diabetic periodontitis, Features: The exosomes derived from periodontal ligament stem cells alleviate high-glucose-induced periodontal ligament stem cell aging by transmitting miR-141-3p to activate the KEAP1-NRF2 signaling pathway; the preparation method of the exosomes is: young periodontal ligament stem cells are cultured in a complete culture medium, and when the cell density reaches more than 60%, the culture medium is replaced with a serum-free culture medium, and the culture is continued for 44-52 hours, and then the cell supernatant is collected to obtain supernatant 1; the obtained supernatant 1 is subjected to differential centrifugation to obtain supernatant 2; the obtained supernatant 2 is subjected to ultracentrifugation and the supernatant is removed to obtain exosomes.
2. The use according to claim 1, Features: The periodontal ligament stem cells are human periodontal ligament stem cells.
3. The use according to claim 1, Features: The medicine consists of an active ingredient and pharmaceutically acceptable excipients, and the active ingredient is exosomes derived from periodontal ligament stem cells.
Citation Information
Cited By
Culture method and application of anti-aging stem cell exosome
CN120137892A
A culture method and application of stem cell exosomes for anti-aging
CN120137892B
